OPA quantification of amino groups at the surface of Lipidic NanoCapsules (LNCs) for ligand coupling improvement

International Journal of Pharmaceutics

Volumn 419, Issue 1-2, 2011, Pages 266-270

  Perrier, Thomas ^a   Fouchet, Florian ^a   Bastiat, Guillaume ^a   Saulnier, Patrick ^a   Benoît, Jean Pierre ^a  

^a INSERM   (France)

Author keywords

Amphiphilic phospholipids; Fluorescence; Lipid Nanocapsules; Post insertion

Indexed keywords

AMINO ACID; LIPIDIC NANOCAPSULE; MACROGOL; MACROGOL 2000; NANOCAPSULE; POLYETHYLENE GLYCOL 660; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CHEMICAL PROCEDURES; CHEMICAL REACTION; CROSS COUPLING REACTION; EMULSION; EMULSION PHASE INVERSION METHOD; HYDRODYNAMICS; MOLECULE; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

EXCIPIENTS; HYDRODYNAMICS; LIGANDS; LIPIDS; NANOCAPSULES; NANOTECHNOLOGY; O-PHTHALALDEHYDE; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS;

EID: 84860417831     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.07.028     Document Type: Article

References (41)

1. T.M. Allen, and P.R. Cullis Drug delivery systems: entering the mainstream Science 303 2004 1818 1822 (Pubitemid 38374867)
2. M. Breunig, S. Bauer, and A. Goepferich Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur. J. Pharm. Biopharm. 68 2008 112 128 (Pubitemid 350181412)
3. K. Cho, X. Wang, S. Nie, Z. Chen, and D.M. Shin Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 14 2008 1310 1316 (Pubitemid 351413909)
4. R.G. Crystal Transfer of genes to humans: early lessons and obstacles to success Science 270 1995 404 410
5. S. David, B. Pitard, J.-P. Benoît, and C. Passirani Non-viral nanosystems for systemic siRNA delivery Pharmacol. Res. 62 2010 100 114
6. M.E. Davis, Z. Chen, and D.M. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discov. 7 2008 771 782
7. A. Des Rieux, V. Fievez, M. Garinot, Y.-J. Schneider, and V. Préat Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach J. Control. Release 116 2006 1 27 (Pubitemid 44792295)
8. M. Donkuru, I. Badea, S. Wettig, R. Verrall, M. Elsabahy, and M. Foldvari Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies Nanomedicine 5 2010 1103 1127
9. S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 2001 494 498 (Pubitemid 32494397)
10. O.C. Farokhzad, J.M. Karp, and R. Langer Nanoparticle-aptamer bioconjugates for cancer targeting Expert Opin. Drug Deliv. 3 2006 311 324 (Pubitemid 43772708)
11. S. Fawell, J. Seery, Y. Daikh, C. Moore, L.L. Chen, B. Pepinsky, and J. Barsoum Tat-mediated delivery of heterologous proteins into cells PNAS 91 1994 664 668 (Pubitemid 24041462)
12. S.-S. Feng Nanoparticles of biodegradable polymers for new-concept chemotherapy Expert Rev. Med. Devices 1 2004 115 125 (Pubitemid 40220423)
13. S. Ganta, H. Devalapally, A. Shahiwala, and M. Amiji A review of stimuli-responsive nanocarriers for drug and gene delivery J. Control. Release 126 2008 187 204
14. J. Gubernator, Z. Drulis-Kawa, and A. Kozubec A simply and sensitive fluorometric method for determination of gentamycin in liposomal suspensions Int. J. Pharm. 327 2006 104 109 (Pubitemid 44667343)
15. B. Heurtault, P. Saulnier, B. Pech, J.E. Proust, and J.P. Benoît Properties of polyethylene glycol 660 12-hydroxy stearate at a triglyceride/water interface Int. J. Pharm. 242 2002 167 170
16. B. Heurtault, P. Saulnier, B. Pech, J.-E. Proust, and J.-P. Benoit A novel phase inversion-based process for the preparation of lipid nanocarriers Pharm. Res. 19 2002 875 880 (Pubitemid 34692585)
17. B. Heurtault, P. Saulnier, B. Pech, M.-C. Venier-Julienne, J.-E. Proust, R. Phan-Tan-Luu, and J.-P. Benoît The influence of lipid nanocapsule composition on their size distribution Eur. J. Pharm. Sci. 18 2003 55 61 (Pubitemid 36120555)
18. S. Hong, P.R. Leroueil, I.J. Majoros, B.G. Orr, J.R. Baker Jr., and M.M. Banaszak Holl The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform Chem. Biol. 14 2007 107 115 (Pubitemid 46124068)
19. J. Huskens, A. Mulder, T. Auletta, C.A. Nijhuis, M.J.W. Ludden, and D.N. Reinhoudt A model for describing the thermodynamics of multivalent host-guest interactions at interfaces J. Am. Chem. Soc. 126 2004 6784 6797 (Pubitemid 38697378)
20. J. Huwyler, D. Wu, and W.M. Pardridge Brain drug delivery of small molecules using immunoliposomes PNAS 93 1996 14164 14169 (Pubitemid 26424263)
21. J.M. Irache, H.H. Salman, C. Gamazo, and S. Espuelas Mannose-targeted systems for the delivery of therapeutics Expert Opin. Drug Deliv. 5 2008 703 724 (Pubitemid 351998259)
22. L.S. Jabr-Milane, L.E. van Vlerken, S. Yadav, and M.M. Amiji Multi-functional nanocarriers to overcome tumor drug resistance Cancer Treatment Rev. 34 2008 592 602
23. P.I. Kitov, and D.R. Bundle On the nature of the multivalency effect: a thermodynamic model J. Am. Chem. Soc. 125 2003 16271 16284 (Pubitemid 38020650)
24. M. Mammen, S.-K. Choi, and G.M. Whitesides Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors Angew. Chem. Int. Ed. 37 1998 2755 2794
25. J.R. McCarthy, and R. Weissleder Multifunctional magnetic nanoparticles for targeted imaging and therapy Adv. Drug Deliv. Rev. 60 2008 1241 1251
26. M. Meyer, and E. Wagner Recent developments in the application of plasmid DNA-based vectors and small interfering RNA therapeutics for cancer Hum. Genet. Ther. 17 2006 1062 1076 (Pubitemid 44749709)
27. M. Morille, C. Passirani, E. Letrou-Bonneval, J.P. Benoit, and B. Pitard Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting Int. J. Pharm. 379 2009 293 300
28. S. Nie, Y. Xing, G.J. Kim, and J.W. Simons Nanotechnology applications in cancer Annu. Rev. Biomed. Eng. 9 2007 257 288 (Pubitemid 350246658)
29. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 2003 329 347 (Pubitemid 36297053)
30. R. Pasqualini, E. Koivunen, and E. Ruoslahti αv integrins as receptors for tumor targeting by circulating ligands Nature Biotechnol. 15 1997 542 546 (Pubitemid 27251571)
31. T. Perrier, P. Saulnier, and J.-P. Benoît Methods for the functionalisation of nanoparticles: new insights and perspectives Chem. A: Eur. J. 16 2010 11516 11529
32. T. Perrier, P. Saulnier, F. Fouchet, N. Lautram, and J.P. Benoît Post-insertion into Lipid NanoCapsules (LNCs): from experimental aspects to mechanisms Int. J. Pharm. 396 2010 204 209
33. J.P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M.J. Gait, L.V. Chernomordik, and B. Lebleu Cell-penetrating peptides: a reevaluation of the mechanism of cellular uptake J. Biol. Chem. 278 2003 585 590 (Pubitemid 36043612)
34. K. Riehemann, S.W. Schneider, T.A. Luger, B. Godin, M. Ferrari, and H. Fuchs Nanomedicine - Challenge and perspectives Angew. Chem. Int. Ed. 48 2009 872 897
35. E. Ruoslahti, and M.D. Pierschbacher New perspectives in cell adhesion: RGD and integrins Science 238 1987 491 497 (Pubitemid 17147032)
36. R. Sinha, G.J. Kim, S. Nie, and D.M. Shin Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery Mol. Cancer Ther. 5 2006 1909 1917 (Pubitemid 44336561)
37. V.P. Torchilin Multifunctional nanocarriers Adv. Drug Deliv. Rev. 58 2006 1532 1555 (Pubitemid 44822608)
38. L.E. Van Vlerken, and M.M. Amiji Multi-functional polymeric nanoparticles for tumour-targeted drug delivery Expert Opin. Drug Deliv. 3 2006 205 216 (Pubitemid 43338092)
39. E. Vivs, P. Brodin, and B. Lebleu A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus J. Biol. Chem. 272 1997 16010 16017 (Pubitemid 27265584)
40. E. Wagner Programmed drug delivery: nanosystems for tumor targeting Expert Opin. Biol. Ther. 7 2007 587 593 (Pubitemid 46707182)
41. T.C. Yih, and M. Al-Fandi Engineered nanoparticles as precise drug delivery systems J. Cell Biochem. 97 2006 1184 1190